SpaceShipTwo Sets its Novel Height Record of 71,000 Feet
According to a new report, virgin's SpaceshipTwo (SS2) has set a new altitude record in its very first test flight in the current year. It has been reported that the Galactic's SpaceShipTwo has attained a height of 71,000 feet at speed of about Mach 1.4, which was accomplished in its third test flight of 2014 on Friday.
The main motive of the flight above the Mojave Air and Space Port is to set the stage for eventual tourist flights into space. This program aims at providing practical sub-orbit space travel for commercial purposes.
The SpaceShipTwo is a reusable spacecraft prototype, which is powered by a hybrid rocket system. Features of the ship are that it uses a rubber compound as well as nitrous oxide to boost the craft at supersonic speeds and contains seat for six passengers along with one pilot seat.
It has been reported that the SpaceShipTwo took off its flight with its mothership, the WhiteKnightTwo at Mojave Air and Space Port near Los Angeles. The SpaceShipTwo was detached from its support to begin the test flight at the height of about 46,000 feet above surface of earth.
Scientists predict the Virgin Galactic SpaceShipTwo will soon offer first commercial space flights this year, after completion of all test flights.
American aviation major Boeing has signaled its intent to unveil a modified version of its 737 MAX 10 aircraft at the opening of the Paris Airshow on Monday this week.
The odd dual-screen device called the YotaPhone 3 has been officially announced in the East Asian country of China for 2017 release.
After successfully launching its first X-ray space telescope, China is now preparing to launch four more space probes before 2021 as part of the ongoing efforts to develop space science.
The European Union (EU) is reportedly preparing to impose a record-high fine on tech giant Google (Alphabet) within the next few weeks, according to a WSJ report.
The U.S. Food & Drug Administration (FDA) has finally approved a new epinephrine injector for anaphylaxis, increasing competition for the controversially expensive injector EpiPen.
CenturyLink stock suffered major setback after Bloomberg published a report citing a former CenturyLink employee claiming that she was fired after she reported about fraud billing practices in the company.